The development of a biosimilar product requires extensive characterization at many stages. At the functional level, pharmacologic activity should be evaluated by appropriate in vitro and/or in vivo assays. However, these potency assays can be expensive and time consuming.
This paper reviews the qualification of cell-based assays for functional comparability analysis that provide an attractive alternative to more expensive and time-consuming assays.
This paper reviews the qualification of cell-based assays for functional comparability analysis that provide an attractive alternative to more expensive and time-consuming assays.
400 Broadacres Drive,
Suite 200, 2nd Floor,
Bloomfield, New Jersey, 07003,
United States